Tighter GMPs a significant risk for Indian drugmakers; CARE
The manufacturing quality clampdown by regulators is a “significant risk” for Indian drugmakers, a credit rating agency said.
Archives for June 24, 2012
Regulatory pressures could help end CMO slump; analyst
Regulatory pressures on drugmakers are pushing contract manufacturing out of a prolonged slump, an analyst said.
Accovion opens Madrid office
German CRO Accovion has opened an office in Madrid to expand its presence in a “key strategic territory.”
Drug delivery developers must simulate device drops; EMA
The EMA is advising manufacturers to simulate dropping a drug delivery device during development to test its robustness.
Catalent and Bend partner on oral controlled-release development
Catalent and Bend Research have joined forces to tackle time and cost restrictions for the complex oral controlled-release development and manufacturing process.